A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2011
11/10/2011	US20110274700 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
11/10/2011	US20110274699 ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
11/10/2011	US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
11/10/2011	US20110274697 Novel uses
11/10/2011	US20110274696 Antibodies to ccr2
11/10/2011	US20110274695 Prodrugs containing novel bio-cleavable linkers
11/10/2011	US20110274694 ERK1/2 Posphorylation Site Specific Antibody
11/10/2011	US20110274693 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
11/10/2011	US20110274692 Screening Methods
11/10/2011	US20110274691 Ferroportin antibodies and methods of use
11/10/2011	US20110274690 Compositions and methods for the diagnosis and treatment of tumor
11/10/2011	US20110274689 Compounds and methods to measure metabolic function and restore normal metabolic function
11/10/2011	US20110274688 Prevention of tumors with monoclonal antibodies against neu
11/10/2011	US20110274687 Methods of treating tslp-related inflammatory disorders
11/10/2011	US20110274686 Antitumor combinations containing antibodies recognizing specifically cd38 and melphalan
11/10/2011	US20110274685 Antibodies that bind human cd27 and uses thereof
11/10/2011	US20110274684 Cytotoxic antibodies directed against antibodies inhibiting factor viii
11/10/2011	US20110274683 Antibodies That Bind CSF1R
11/10/2011	US20110274658 Chimeric activators: quantitatively designed protein therapeutics and uses thereof
11/10/2011	US20110274657 Oxadiazole derivatives as s1p1 receptor antagonists
11/10/2011	US20110274653 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	US20110274651 Noscapine and Noscapine Analogs and Their Use in treating Infectious Diseases by Tubulin Binding Inhibition
11/10/2011	US20110274649 T-cell vaccination with viral vectors via mechanical epidermal disruption
11/10/2011	US20110274616 4-(2,6-dichloro-benzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
11/10/2011	CA2835313A1 Gfi1b modulation and uses thereof
11/10/2011	CA2805267A1 Detection and treatment of fibrosis
11/10/2011	CA2798764A1 Genetic signatures in hiv-1 subtype c envelope glycoproteins
11/10/2011	CA2798616A1 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	CA2798355A1 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
11/10/2011	CA2798151A1 Immunogen adherence and method of making and using same
11/10/2011	CA2798139A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
11/10/2011	CA2797846A1 Methods for the treatment of il-1.beta. related conditions
11/10/2011	CA2794864A1 Compositions and methods useful for reducing the viscosity of protein-containing formulations
11/10/2011	CA2793544A1 Compositions and methods for the diagnosis and treatment of tumor
11/09/2011	EP2385124A2 Peptides or peptide analogues for modulating the binding of a PDZ protein and a PL protein
11/09/2011	EP2385114A1 Diagnosis of treatment of cancer using anti-tm4sf20 antibody
11/09/2011	EP2385107A1 Lentiviral vector based immunological compounds against malaria
11/09/2011	EP2385070A1 Il-18 binding proteins
11/09/2011	EP2385069A2 Neonatal Fc rReceptor (FcRn)- binding polypeptide variants, dimeric Fc binding proteins and methods related thereto
11/09/2011	EP2385068A1 Polyclonal antiserum for use in immunotherapy
11/09/2011	EP2385066A1 Recombinant MHC Molecules Useful for Manipulation of Antigen-Specific T Cells
11/09/2011	EP2385062A2 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
11/09/2011	EP2385060A2 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
11/09/2011	EP2385059A2 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
11/09/2011	EP2385058A1 Method for detecting the expression of a human endogenous retrovirus envelope protein and uses of a coding gene for said protein
11/09/2011	EP2384767A1 Antibodies that bind OV064 and methods of use therefor
11/09/2011	EP2384766A1 Novel antibody to a carbonic anhydrase
11/09/2011	EP2384765A2 Streptococcus pneumoniae vaccine
11/09/2011	EP2384339A2 Treatment of autoimmune disease by modulating annexin-1 (lipocortin 1)
11/09/2011	EP2384201A1 Polypeptides for inducing a protective immune response against staphylococcus aureus
11/09/2011	EP2384196A2 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
11/09/2011	EP2384115A1 Methods and compositions for treating hematological malignancies
11/09/2011	EP1592796B1 Helminth-derived antigens having capacity of providing protection against parasites
11/09/2011	EP1513554B9 Cd16a binding proteins and use for the treatment of immune disorders
11/09/2011	EP1476182B1 Process for preparation of immunogenic formulations of variable peptidic epitopes
11/09/2011	EP1313769B2 Antibodies to human il-1 beta
11/09/2011	EP1001815B1 Vectors derived from antibodies for transferring substances into cells
11/09/2011	CN1980693B P. gingivalis vaccine
11/09/2011	CN1422950B Recombinant gland-related virus expressing human blood angiotonin II receptor I antisense gene and preparation method thereof
11/09/2011	CN102239253A Glutamyl trna synthetase (GTS) fragments
11/09/2011	CN102239252A Infectious bronchitis vaccines derived from ib-qx-like strains
11/09/2011	CN102239251A Bovine viral diarrhea virus with a modified erns protein
11/09/2011	CN102239178A Inhibition of plgf to treat philadelphia chromosome positive leukemia
11/09/2011	CN102238963A Fully human influenza m2 specific antibodies
11/09/2011	CN102238962A Anti-ferroportin 1 monoclonal antibodies and uses thereof
11/09/2011	CN102238961A Bovine herpes virus -1 compositions, vaccines and methods
11/09/2011	CN102238960A Process for production of vaccines
11/09/2011	CN102234657A Fusion protein for resisting chicken coccidiosis, preparation and application thereof
11/09/2011	CN102234645A Artificially synthesized promoter for gene therapy and vaccine development
11/09/2011	CN102234637A Preparation for reconstruction influenza A H1N1 virus inactivated vaccine strain (SC/PR8), and use thereof
11/09/2011	CN102234636A Preparation and application of recombinant influenza A (H1N1) virus cold-adapted attenuated live vaccine strain (SC/AAca)
11/09/2011	CN102234334A Immunoglobulin chimeric monomer - dimer heterozygote
11/09/2011	CN102233137A Recombinant plasmid DNA vaccine composition for treating Hepatitis B
11/09/2011	CN102233136A Recombinant plasmid vaccine for treating hepatitis B and composition thereof
11/09/2011	CN102233134A Slit-Robo-mediated lymph vessel formation and application
11/09/2011	CN102233133A Preparation method and application of Newcastle disease virus infected immune complex vaccines
11/09/2011	CN102233132A Application of VEGF acceptor fusion proteins in preparation of drugs for inhibiting growth of ocular surface neovascularization
11/09/2011	CN102233131A Goat pox oral vaccine using attenuated salmonella as vector and preparation method
11/09/2011	CN102233128A Use of p75neurotrophin receptor-extracellular domain (p75NTR-ECD) in medicine for preventing and treating Alzheimer disease
11/09/2011	CN102232971A Application of Coryebacterium parvum or its composition in preparing medicaments for treating hepatitis B
11/09/2011	CN101704891B Antibody for epidermal growth factor receptor, encoding gene thereof and application thereof
11/09/2011	CN101633910B Rotavirus gene recombined strain and construction method and application thereof
11/09/2011	CN101612394B Streptococcus-pneumoniae-toxicity-reducing live vaccine
11/09/2011	CN101343251B Thrombopoietin mimetics
11/09/2011	CN101280016B Cocaine-and amphetamine-regulated transcript peptides single-chain antibody and application thereof
11/09/2011	CN101060859B Refrigerator-temperature stable influenza vaccine compositions
11/09/2011	CN101010099B Edible vaccine
11/08/2011	US8053564 Biological effectors; S-[3-({2-(3-{[3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl]amino}propoxy)-1,1-bis[3-{[3-(2,5-dioxo-2,5-dihydro-1 H-pyrrol-1-yl)propanoyl]amino}propoxy)methyl]ethyl}amino)-3-oxopropyl]ethanethioate
11/08/2011	US8053558 Dendritic cell co-stimulatory molecules
11/08/2011	US8053556 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
11/08/2011	US8053553 Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
11/08/2011	US8053551 Comprises six transmembrane epithelial antigen of the prostate-2 protein (STEAP)) for diagnosis and treatment of cell proliferative and tumor disorders; genetic vaccine; antitumor agents
11/08/2011	US8053421 DNA vaccines against tumor growth and methods of use thereof
11/08/2011	US8053414 Methods of using B7-DC molecules to induce or enhance an immune response
11/08/2011	US8053206 Antagonists of HMG1 for treating inflammatory conditions
11/08/2011	US8053203 Methods and device for the detection of occult blood
11/08/2011	US8052981 Mono- and disaccharide derivatives
11/08/2011	US8052980 Use of the neurotoxic component of a botulinum toxin for treating arthritis
11/08/2011	US8052979 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
11/08/2011	US8052978 Vaccine composition against Rhodococcus equi

1 ... 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 ... 1823